| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 42 |
| 1 | LEVETIRACETAM | 37 |
| 2 | NIVOLUMAB | 36 |
| 3 | IPILIMUMAB | 32 |
| 4 | DEXAMETHASONE | 31 |
| 5 | DEXAMETHASONE 1.5 MG | 31 |
| 6 | TEMOZOLOMIDE | 22 |
| 7 | LEVETIRACETAM IN SODIUM CHLORIDE | 17 |
| 8 | LEVETIRACETAM INJECTION | 17 |
| 9 | LEVETIRACETAM ORAL | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOVORAFENIB | 10 | 0.0307 |
| 1 | ALMOTRIPTAN | 4 | 0.0038 |
| 2 | BELZUTIFAN | 6 | 0.0034 |
| 3 | BINIMETINIB | 10 | 0.0013 |
| 4 | ZOLMITRIPTAN | 9 | 0.0012 |
| 5 | ENTRECTINIB | 2 | 0.0012 |
| 6 | VEMURAFENIB | 14 | 0.0012 |
| 7 | TEMOZOLOMIDE | 22 | 0.0010 |
| 8 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 2 | 0.0009 |
| 9 | DESMOPRESSIN ACETATE | 3 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 32 | 0.0007 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 49 | 0.0005 |
| 6 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 7 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 9 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |